A vitamin D3 derivative (CB1093) induces nerve growth factor and prevents neurotrophic deficits in streptozotocin-diabetic rats

Diabetologia

Volumn 42, Issue 11, 1999, Pages 1308-1313

  Riaz, S ^a   Malcangio, M ^a   Miller, M ^b   Tomlinson, D R ^c  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b Cephalon Inc   (United States)

^c School of Biological Sciences   (United Kingdom)

Author keywords

CGRP; Nerve conduction velocity; Nerve growth factor; Neuropathy; NGF receptors; Nociception; P75(NTR); Substance P; trkA; Vitamin D3

Indexed keywords

20 EPI 22 ETHOXY 24A,26A,27A TRIHOMO 9,10 SECOCHOLESTA 5,7,10(19) TRIEN 23 YNE 1ALPHA,3BETA,25 TRIOL; ANTIDIABETIC AGENT; COLECALCIFEROL DERIVATIVE; NERVE GROWTH FACTOR; STREPTOZOCIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFICACY; DRUG MECHANISM; HUMAN; MALE; NERVE GROWTH; NEUROTROPISM; NOCICEPTION; NONHUMAN; ORAL DRUG ADMINISTRATION; PAIN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; STREPTOZOCIN DIABETES; VITAMIN METABOLISM;

ANIMALS; CALCITRIOL; DIABETES MELLITUS, EXPERIMENTAL; HINDLIMB; HOMEOSTASIS; MALE; MUSCLE, SKELETAL; NERVE GROWTH FACTOR; NERVOUS SYSTEM; NEURAL CONDUCTION; NEUROPEPTIDES; NOCICEPTORS; RATS; RATS, WISTAR; RECEPTOR, NERVE GROWTH FACTOR; RECEPTOR, TRKA; RNA, MESSENGER; SCIATIC NERVE; SKIN; TIME FACTORS;

EID: 0032708935     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250051443     Document Type: Article

References (37)

1. 1. Hellweg R, Hartung H-D (1990) Endogenous levels of nerve growth factor (NGF) are altered in experimental diabetes mellitus: A possible role for NGF in the pathogenesis of diabetic neuropathy. J Neurosci Res 26: 258-267
2. 2. Fernyhough P, Diemel LT, Brewster WJ, Tomlinson DR (1995) Altered neurotrophin mRNA in peripheral nerve and skeletal muscle of experimentally diabetic rats. J Neurochem 64: 1231-1237
3. 3. Anand P, Terenghi G, Warner G, Kopelman PG, Williams-Chestnut RE, Sinicropi DV (1996) The role of endogenous nerve growth factor in human diabetic neuropathy. Nature Med 2: 703-707
4. 4. Fernyhough P, Diemel LT, Brewster WJ, Tomlinson DR (1994) Deficits in sciatic nerve neuropeptide content coincide with a reduction in target tissue nerve growth factor mRNA in streptozotocin-diabetic rats; effects of insulin treatment. Neuroscience 62: 337-344
5. 5. Fernyhough P, Diemel LT, Hardy J, Brewster WJ, Mohiuddin L, Tomlinson DR (1995) Human recombinant nerve growth factor replaces deficient neurotrophic support in the diabetic rat. Eur J Neurosci 7: 1107-1110
6. 6. Apfel SC, Kessler JA, Adornato BT et al. (1998) Recombinant human nerve growth factor in the treatment of diabetic polyneuropathy. Neurology 51: 695-702
7. 7. Dyck PJ, Peroutka S, Rask C et al. (1997) Intradermal recombinant human nerve growth factor induces pressure allodynia and lowered heat-pain threshold in humans. Neurology 48: 501-505
8. 8. Furukawa S, Furukawa Y (1990) Nerve growth factor synthesis and its regulatory mechanisms: an approach to therapeutic induction of nerve growth factor synthesis. Cerebrovasc Brain Metab Rev 2: 328-344
9. 9. Riaz SS, Tomlinson DR (1996) Neurotrophic factors in peripheral neuropathies: pharmacological strategies. Prog Neurobiol 49: 125-143
10. 3 is a potent inducer of nerve growth factor synthesis. J Neurosci Res 28: 110-114
11. 3 regulates the synthesis of nerve growth factor in primary cultures of glial cells. Mol Brain Res 24: 70-76
12. 3 regulates NT-3, NT-4 but not BDNF mRNA in astrocytes. Neuroreport 6: 124-126
13. 13. Saporito MS, Wilcox HM, Hartpence KC, Lewis ME, Vaught JL, Carswell S (1993) Pharmacological induction of nerve growth factor mRNA in adult rat brain. Exp Neurol 123: 295-302
14. 3-mediated induction of nerve growth factor mRNA and protein in L929 fibroblasts and in adult rat brain. Brain Res 633: 189-196
15. 15. Binderup L, Bramm E (1988) Effects of a novel vitamin D analogue MC903 on cell proliferation and differentiation in vitro and on calcium metabolism in vivo. Biochem Pharmacol 37: 889-895
16. 16. Robbins E, Dobrzansky P, Haun K et al. (1997) Efficacy of orally-administered CB-1093, an NGF-inducing vitamin D receptor ligand, in the fimbria fornix lesion model. Society for Neuroscience Abstracts 23: 881
17. 17. Malcangio M, Garrett NE, Cruwys SC, Tomlinson DR (1997) Nerve growth factor and neurotrophin-3 induced changes in nociceptive threshold and the release of substance P from the rat isolated spinal cord. J Neurosci 17: 8459-8467
18. 18. Hounsom L, Horrobin DF, Tritschler H, Corder R, Tomlinson DR (1998) A lipoic acid-gamma linolenic acid congugate is effective against multiple indices of experimental diabetic neuropathy. Diabetologia 41: 839-843
19. 19. Diemel LT, Brewster WJ, Fernyhough P, Tomlinson DR (1994) Expression of neuropeptides in experimental diabetes; effects of treatment with nerve growth factor or brain-derived neurotrophic factor. Mol Brain Res 21: 171-175
20. 20. Chomczynski P, Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159
21. 21. Maeda K, Fernyhough P, Tomlinson DR (1997) Effects of treatment of diabetic rats with human recombinant nerve growth factor on sciatic nerve conduction, Doppler flux and substance P levels. Diabetes Nutr Metab 10: 3-8
22. 22. Lindsay RM, Lockett C, Sternberg J, Winter J (1989) Neuropeptide expression in cultures of adult sensory neurons: Modulation of substance P and calcitonin gene-related peptide levels by nerve growth factor. Neuroscience 33: 53-65
23. 23. Lindsay RM, Harmar AJ (1989) Nerve growth factor regulates expression of neuropeptide genes in adult sensory neurons. Nature 337: 362-364
24. NTR protein in lumbar dorsal root ganglia. Mol Brain Res 51: 82-90
25. 25. Ahlgren SC, White DM, Levine JD (1992) Increased responsiveness of sensory neurons in the saphenous nerve of the streptozotocin-diabetic rat. J Neurophysiol 68: 2077-2085
26. 26. Ahlgren SC, Levine JD (1993) Mechanical hyperalgesia in streptozotocin-diabetic rats is not sympathetically maintained. Brain Res 616: 171-175
27. 27. Ahlgren SC, Levine JD (1993) Mechanical hyperalgesia in streptozotocin-diabetic rats. Neuroscience 52: 1049-1055
28. 28. Ahlgren SC, Levine JD (1994) Protein kinase C inhibitors decrease hyperalgesia and C-fiber hyperexcitability in the streptozotocin-diabetic rat. J Neurophysiol 72: 684-692
29. 29. Baron R, Maier C (1995) Painful neuropathy: C-nociceptor activity may not be necessary to maintain central mechanisms accounting for dynamic mechanical allodynia. Clin J Pain 11: 63-69
30. 30. Malcangio M, Tomlinson DR (1998) A pharmacologic analysis of mechanical hyperalgesia in streptozotocin/diabetic rats. Pain 76: 151-157
31. 31. Wassner SJ, Li JB, Sperduto A, Norman ME (1983) Vitamin D Deficiency, hypocalcemia, and increased skeletal muscle degradation in rats. J Clin Invest 72: 102-112
32. 32. Giuliani DL, Boland RL (1984) Effects of vitamin D3 metabolites on calcium fluxes in intact chicken skeletal muscle and myoblasts cultured in vitro. Calcif Tissue Int 36: 200-205
33. 33. Massheimer V, Fernandez LM, de-Boland AR (1990) Stimulation of calmodulin binding to skeletal muscle membrane proteins by 1,25-dihydroxy-vitamin D3. Z Naturforsch C 45: 663-670
34. 34. Vazquez G, de-Boland AR, Boland R (1997) Stimulation of Ca2 + release-activated Ca2 + channels as a potential mechanism involved in non-genomic 1,25(OH)2-vitamin D3-induced Ca2 + entry in skeletal muscle cells. Biochem Biophys Res Commun 239: 562-565
35. 35. Selles J, Massheimer V, Santillan G, Marinissen MJ, Boland R (1997) Effects of calcitriol and its analogues, calcipotriol (MC 903) and 20-epi-1alpha,25-dihydroxyvitamin D3 (MC 1288), on calcium influx and DNA synthesis in cultured muscle cells. Biochem Pharmacol 53: 1807-1814
36. 36. Ishida H, Seino Y, Tsuda K et al. (1983) Effects of streptozotocin-induced diabetes on circulating levels of vitamin D metabolites. Acta Endocrinol (Copenh ) 104: 96-102
37. 37. Storm TL, Sorensen OH, Lund B et al. (1983) Vitamin D metabolism in insulin-dependent diabetes mellitus. Metab Bone Dis Related Res 5: 107-110